Minimizing bleeding events.

Agewall, Stefan

Agewall, Stefan.

Agewall S; Editor-in-Chief, Oslo University Hospital Ullevål and Institute of Clinical Sciences, University of Oslo, Oslo, Norway.

Eur Heart J Cardiovasc Pharmacother ; 6(5): 271-272, 2020 09 01.

Article in English | MEDLINE | ID: covidwho-955019

Subject(s)

Anti-Inflammatory Agents, Non-Steroidal/therapeutic use; Anticoagulants/therapeutic use; Hemorrhage/prevention & control; Platelet Aggregation Inhibitors/therapeutic use; Angiotensin II Type 1 Receptor Blockers/therapeutic use; Anti-Inflammatory Agents, Non-Steroidal/adverse effects; Anticoagulants/adverse effects; Antiviral Agents/therapeutic use; COVID-19; Coronavirus Infections/drug therapy; Coronavirus Infections/virology; Dual Anti-Platelet Therapy; Hemorrhage/chemically induced; Humans; Pandemics; Platelet Aggregation Inhibitors/adverse effects; Pneumonia, Viral/drug therapy; Pneumonia, Viral/virology; Risk Assessment; COVID-19 Drug Treatment

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Platelet Aggregation Inhibitors / Anti-Inflammatory Agents, Non-Steroidal / Hemorrhage / Anticoagulants Type of study: Prognostic study Limits: Humans Language: English Journal: Eur Heart J Cardiovasc Pharmacother Year: 2020 Document Type: Article Affiliation country: Ehjcvp

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google